Member Publications - 2002

January

1. Acute stress disorder following ventilation. Shaw RJ, Robinson TE, Steiner H. Psychosomatics. 2002 Jan-Feb;43(1):74-6.
   
   
2. Long-term benefits of inhaled tobramycin in adolescent patients with cystic fibrosis. Moss RB. Chest. 2002 Jan;121(1):55-63.

February

March

April

May

June

July

1. A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies. Wagner JA, Nepomuceno IB, Messner AH, Moran ML, Batson EP, Dimiceli S, Brown BW, Desch JK, Norbash AM, Conrad CK, Guggino WB, Flotte TR, Wine JJ, Carter BJ, Reynolds TC, Moss RB, Gardner P. Hum Gene Ther. 2002 Jul 20;13(11):1349-59.

August

1. Allergic bronchopulmonary aspergillosis. Moss RB. Clin Rev Allergy Immunol. 2002 Aug;23(1):87-104. Review.

September

October 

November

1. Contribution of the K(Ca) channel to membrane potential and O2 sensitivity is decreased in an ovine PPHN model. Olschewski A, Hong Z, Linden BC, Porter VA, Weir EK, Cornfield DN. Am J Physiol Lung Cell Mol Physiol. 2002 Nov;283(5):L1103-9.
   
   
2. Interactive effects of high-frequency oscillatory ventilation and inhaled nitric oxide in acute hypoxemic respiratory failure in pediatrics. Dobyns EL, Anas NG, Fortenberry JD, Deshpande J, Cornfield DN, Tasker RC, Liu P, Eells PL, Griebel J, Kinsella JP, Abman SH. Crit Care Med. 2002 Nov;30(11):2425-9.
   
   
3. PML-dependent apoptosis after DNA damage is regulated by the checkpoint kinase hCds1/Chk2. Yang S, Kuo CS, Bisi JE, Kim MK. Nat Cell Biol. 2002 Nov;4(11):865-70.

December

1. Continuous propofol infusion in 142 critically ill children. Cornfield DN, Tegtmeyer K, Nelson MD, Milla CE, Sweeney M. Pediatrics. 2002 Dec;110(6):1177-81.
   
   
2. Pulmonary vascular K+ channel expression and vasoreactivity in a model of congenital heart disease. Cornfield DN, Resnik ER, Herron JM, Reinhartz O, Fineman JR. Am J Physiol Lung Cell Mol Physiol. 2002 Dec;283(6):L1210-9.